Anika Therapeutics (ANIK) EBT Margin (2010 - 2026)
Anika Therapeutics' (ANIK) quarterly EBT Margin came in at 10.36% in Q2 2026, up 2442.0% year-over-year from 0.41% in Q2 2025, and up 163.66% quarter-over-quarter from 16.28% in Q1 2026.
Powered by 
Analysis
Anika Therapeutics (ANIK) EBT Margin (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported EBT Margin for 17 consecutive years, with 10.36% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin rose 2442.0% year-over-year to 10.36% in Q2 2026; TTM through Jun 2026 was 3.19%, a 448.0% increase from a year earlier, with the FY2025 full-year figure at 9.08%, down 568.0% from the prior year.
- EBT Margin was 10.36% for Q2 2026 at Anika Therapeutics, up from 16.28% in the prior quarter.
- Over five years, EBT Margin peaked at 10.36% in Q2 2026 and troughed at 871.99% in Q4 2023.
- A 5-year average of 89.71% and a median of 9.19% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin plunged 57992 bps in 2022 and surged 86782 bps in 2024, its largest moves.
- Over 5 years, EBT Margin stood at 598.46% in 2022, then plunged by 46 bps to 871.99% in 2023, then surged by 100 bps to 4.17% in 2024, then surged by 86 bps to 0.57% in 2025, then jumped by 1903 bps to 10.36% in 2026.
- The last three EBT Margin figures came in at 10.36% (Q2 2026), 16.28% (Q1 2026), and 0.57% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.32% |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | 10.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.36% |
| Mar 31, 2026 | -16.28% |
| Dec 31, 2025 | -0.57% |
| Sep 30, 2025 | -8.04% |
| Jun 30, 2025 | -14.05% |
| Mar 31, 2025 | -14.79% |
| Dec 31, 2024 | -4.17% |
| Sep 30, 2024 | 1.10% |
| Jun 30, 2024 | -3.95% |
| Mar 31, 2024 | -6.59% |
| Dec 31, 2023 | -871.99% |
| Sep 30, 2023 | -16.98% |
| Jun 30, 2023 | -6.93% |
| Mar 31, 2023 | -31.68% |
| Dec 31, 2022 | -598.46% |
| Sep 30, 2022 | -13.32% |
| Jun 30, 2022 | -8.28% |
| Mar 31, 2022 | -10.11% |
| Dec 31, 2021 | -18.54% |
| Sep 30, 2021 | 3.17% |